What Fueled The Previous Growth In The Nucleic Acid Amplification Testing Market?
The nucleic acid amplification testing market has seen considerable growth due to a variety of factors.
• In recent times, the market size of nucleic acid amplification testing has seen a significant increase. It is predicted that the current market value of $9.56 $ billion in 2024 will grow to $11.03 $ billion in 2025 with a compound annual growth rate (CAGR) of 15.3%.
The noticeable growth during the historic period can be traced back to increased awareness about infectious disease diagnosis, identification of new pathogens, a shift in focus towards personalized medicine, a rise in demand for point-of-care testing, as well as regulatory approvals and guidelines.
What Can Be Expected from the Nucleic Acid Amplification Testing Market Size?
The nucleic acid amplification testing market is expected to maintain its strong growth trajectory in upcoming years.
• Expectations are high for the nucleic acid amplification testing market, with the anticipation of swift growth in the coming years. The market is projected to rise to $19.26 billion in 2029, expanding at a compound annual growth rate (CAGR) of 15.0%.
This expected growth within the forecast period can be linked to the increasing prevalence of infectious diseases, the need for extensive testing capacity, and increased investment from private entities. Additionally, there is a growing need for quick and precise testing methods, as well as advanced diagnostic measures. Looking forward, key trends for the forecast period include the incorporation of artificial intelligence (AI), advancements in wearable and implantable technology, wider adoption in point-of-care testing, growth in the field of personalized medicine, and the fusion of digital health technologies.
What Are the Critical Driver Fuelling The Nucleic Acid Amplification Testing Market's Growth?
The nucleic acid amplification testing market's growth is anticipated to be driven by the rising prevalence of infectious diseases. Infectious diseases are ailments that can be directly or indirectly transmitted from one person to another through various channels such as close contact, airborne transmission, consumption of unclean food or water, or through vectors like insects. The surge in infectious diseases can be attributed to factors like antibiotic resistance, climate change, changes in human behavior, and agricultural practices. Nucleic acid amplification testing (NAAT) promptly and precisely detects infectious pathogens, which enables prompt diagnosis and treatment, consequently aiding in disease control. For example, the Public Health Agency of Canada, a government entity based in Canada, reported that during the 2022–2023 season, there were 4,216 hospitalizations related to influenza in participating provinces and territories. The escalating prevalence of infectious diseases, therefore, fuels the expansion of the nucleic acid amplification testing market.
How Is The Nucleic Acid Amplification Testing Market segmented?
The nucleic acid amplification testingmarket covered in this report is segmented –
1) By Type: Target Amplification Systems, Probe Amplification Systems, Signal Amplification Systems
2) By Product Type: Consumables, Instruments Or Systems
3) By Technology: Polymerase Chain Reaction (PCR) Tests, Isothermal Nucleic Acid Amplification Technology (INAAT) Tests, Ligase Chain Reaction (LCR) Tests
4) By Application: Infectious Disease Testing, Oncology Testing, Genetic And Mitochondrial Disease Testing, Other Applications
5) By End-Use: Hospitals, Diagnostic Laboratories, Biotechnology Companies, Other End-Users
Subsegments:
1) By Target Amplification Systems: Polymerase Chain Reaction (PCR), Real-Time PCR (qPCR), Reverse Transcription PCR (RT-PCR), Nested PCR, Multiplex PCR, LAMP (Loop-Mediated Isothermal Amplification),
2) By Probe Amplification Systems: Nucleic Acid Sequence-Based Amplification (NASBA), Hybridization-Based Amplification, Branch Chain Amplification (BCA), Strand Displacement Amplification (SDA),
3) By Signal Amplification Systems: Enzyme-Linked Signal Amplification, Fluorescent Signal Amplification, Chemiluminescent Signal Amplification, Electrochemical Signal Amplification, Magnetic Particle-Based Signal Amplification
Pre-Book The Nucleic Acid Amplification Testing Global Market Report 2025 Report For Swift Delivery And Comprehensive Insights:
How Are New Trends Impacting The Size Of The Nucleic Acid Amplification Testing Market?
Key players in the nucleic acid amplification testing market are making strides towards creating novel solutions like in vitro diagnostics (IVD) assays to scan donor blood for CMV using nucleic acid amplification technology (NAT) under the IVDR. The IVD assay is a laboratory-based testing process utilised on biological specimens for diagnosing diseases, conditions, or infections outside the human body. For instance, GFE, a company located in Germany, introduced the PoET CMV in June, 2024. PoET CMV, a type of IVD assay, has been engineered for the quick and accurate detection of cytomegalovirus (CMV) infections. It boasts unique attributes such as high sensitivity and specificity, which facilitate early detection and efficient tracking of CMV in immunocompromised individuals and transplant patients. The assay uses sophisticated molecular techniques to produce reliable results promptly, aiding in swift clinical decision-making.
Who Are the Key Players In The Nucleic Acid Amplification Testing Market?
Major companies operating in the nucleic acid amplification testing market are:
• F. Hoffmann-La Roche Ltd.
• Thermo Fisher Scientific Inc.
• Abbott Laboratories
• Merck KGaA
• Siemens Healthineers
• Becton
• Dickinson and Company
• Laboratory Corporation of America Holdings
• Quest Diagnostics
• Agilent Technologies Inc.
• Grifols S.A.
• Hologic Inc.
• bioMerieux SA
• QuidelOrtho Corporation
• Bio-Rad Laboratories Inc.
• Cepheid Inc.
• GenScript Biotech Corporation
• ARUP Laboratories
• BGI Group
• Promega Corporation
• Meridian Bioscience Inc.
• Takara Bio Inc.
• Eiken Chemical Co. Ltd.
• New England Biolabs Inc.
• TwistDx Limited
• Bioneer Corporation
What Is The Most Dominant Region In The Nucleic Acid Amplification Testing Market?
North America was the largest region in the nucleic acid amplification testing (NAAT) market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the nucleic acid amplification testing market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.
